Peterman TA, Su J, Bernstein KT, Weinstock H. Syphilis in the United States: on the rise? Expert Rev Anti Infect Ther. 2014;9:1–8.
Google Scholar
Wang X, Lan G, Shen Z, Vermund H, Zhu Q, Chen Y, et al. HIV and syphilis prevalence trends among men who have sex with men in Guangxi, China: yearly cross-sectional surveys, 2008–2012. BMC Infect Dis. 2014;14:367.
Article
PubMed
PubMed Central
Google Scholar
Botham SJ, Ressler KA, Maywood P, Hope KG, Bourne CP, Conaty SJ, et al. Men who have sex with men, infectious syphilis and HIV coinfection in inner Sydney: results of enhanced surveillance. Sex Health. 2013;10(4):291–8.
Article
PubMed
Google Scholar
World Health Organization. Global incidence and prevalence of selected curable sexually transmitted infections—2008. World Health Organization, Geneva, Switzerland 2012. Last accessed on August 29,2015 at: http://apps.who.int/iris/bitstream/10665/75181/1/9789241503839_eng.pdf?ua=1.
Kuklová I, Kojanová M, Zákoucká H, Pánková R, Velcevský P, Rozehnalová Z, et al. Dermatovenereology in the <?show [?A3B2 show $9#?]?>post-communist era: syphilis in Prague during 1999 to 2005. Dermatol Clin. 2008;26:231–7.
Article
PubMed
Google Scholar
Tucker JD, Cohen MS. China’s syphilis epidemic: epidemiology, proximate determinants of spread, and control responses. Curr Opin Infect Dis. 2011;24:50–5.
Article
PubMed
PubMed Central
Google Scholar
Darrow WW, Echenberg DF, Jaffe HW, O'Malley PM, Byers RH, Getchell JP, et al. Risk factors for human immunodeficiency irus (HIV) infections in homosexual men. Am J Public Health. 1987;77:479–83.
Article
CAS
PubMed
PubMed Central
Google Scholar
Otten Jr MW, Zaidi AA, Peterman TA, et al. High rate of HIV seroconversion among patients attending urban sexually transmitted disease clinics. AIDS. 1994;8:549–53.
Article
PubMed
Google Scholar
Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999;75(1):3–17.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kalichman SC, Pellowski J, Turner C. Prevalence of sexually transmitted co-infections in people living with HIV/AIDS: systematic review with implications for using HIV treatments for prevention. Sex Transm Infect. 2011;87:183–90.
Article
PubMed
PubMed Central
Google Scholar
Larsen SA, Steiner BM, Rudolph AH. Laboratory diagnosis and interpretation of tests for syphilis. Clin Microbiol Rev. 1995;8:1–21.
CAS
PubMed
PubMed Central
Google Scholar
Grange PA, Gressier L, Dion PL, Farhi D, Benhaddou N, Gerhardt P, et al. Evaluation of a PCR test for detection of Treponema pallidum in swabs and blood. J Clin Microbiol. 2012;50(3):546–52.
Article
CAS
PubMed
PubMed Central
Google Scholar
Castro R, Prieto E, Aguas MJ, Manata MJ, Botas J, Pereira FM. Detection of Treponema pallidum sp pallidum DNA in latent syphilis. Int J STD AIDS. 2007;18(12):842–5.
Article
CAS
PubMed
Google Scholar
Belisle JT, Brandt ME, Radolf JD, Norgard MV. Fatty acids of Treponema pallidum and Borrelia burgdorferi lipoproteins. J Bacteriol. 1994;176(8):2151–7.
CAS
PubMed
PubMed Central
Google Scholar
Centers for Disease Control and Prevention. Treatment guidelines for sexually transmitted diseases (STDs). Morb Mortal Wkly Rep. 1982;31:33S–60.
Google Scholar
Guinan ME. Treatment of primary and secondary syphilis: defining failure at three- and six- month follow-up. JAMA. 1987;257(3):359–60.
Article
CAS
PubMed
Google Scholar
Brown ST, Zaidi A, Larsen SA, Reynolds GH. Serological response to syphilis treatment. A new analysis of old data. JAMA. 1985;253(9):1296–9.
Article
CAS
PubMed
Google Scholar
De Santis M, De Luca C, Mappa I, Spagnuolo T, Licameli A, Straface G, et al. Syphilis infection during pregnancy: fetal risks and clinical management. Infect Dis Obstet Gynecol. 2012;2012:430585.
Article
PubMed
PubMed Central
Google Scholar
Centers for Disease Control and Prevention. Congenital syphilis - United States, 2003–2008. MMWR Morb Mortal Wkly Rep. 2010;59(14):413–7.
Google Scholar
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology. 2007;18(6):800–4.
Article
Google Scholar
Dionne-Odom J, Karita E, Kilembe W, Henderson F, Vwalika B, Bayingana R, et al. Syphilis treatment response among HIV-discordant couples in Zambia and Rwanda. Clin Infect Dis. 2013;56(12):1829–37.
Article
PubMed
PubMed Central
Google Scholar
Fiumara NJ. Serologic responses to treatment of 128 patients with late latent syphilis. Sex Transm Dis. 1979;6(4):243–6.
Article
CAS
PubMed
Google Scholar
Ghanem KG, Erbelding EJ, Wiener ZS, Rompalo AM. Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics. Sex Transm Infect. 2007;83(2):97–101.
Article
CAS
PubMed
Google Scholar
Ghanem KG, Moore RD, Rompalo AM, Erbelding EJ, Zenilman JM, Gebo KA. Antiretroviral therapy is associated with reduced serologic failure rates for syphilis among HIV-infected patients. Clin Infect Dis. 2008;47(2):258–65.
Article
PubMed
PubMed Central
Google Scholar
Jinno S, Anker B, Kaur P, Bristow CC, Klausner JD. Predictors of serological failure after treatment in HIV-infected patients with early syphilis in the emerging era of universal antiretroviral therapy use. BMC Infect Dis. 2013;13:605.
Article
PubMed
PubMed Central
Google Scholar
Knaute DF, Graf N, Lautenschlager S, Weber R, Bosshard PP. Serological response to treatment of syphilis according to disease stage and HIV status. Clin Infect Dis. 2012;55(12):1615–22.
Article
CAS
PubMed
PubMed Central
Google Scholar
Li J, Wang LN, Zheng HY. Predictors of serological cure and serofast state after treatment in HIV-negative patients with early syphilis in China. Sex Transm Infect. 2013;89(1):69.
Article
PubMed
Google Scholar
Malone JL, Wallace MR, Hendrick BB, LaRocco A Jr, Tonon E, Brodine SK, et al. Syphilis and neurosyphilis in a human immunodeficiency virus type-1 seropositive population: Evidence for frequent serologic relapse after therapy. Am J Med. 1995;99(1):55–63.
Article
CAS
PubMed
Google Scholar
Romanowski B, Sutherland R, Fick GH, Mooney D, Love EJ. Serologic response to treatment of infectious syphilis. Ann Intern Med. 1991;114(12):1005–9.
Article
CAS
PubMed
Google Scholar
Tittes J, Aichelburg MC, Antoniewicz L, Geusau A. Enhanced therapy for primary and secondary syphilis: a longitudinal retrospective analysis of cure rates and associated factors. Int J STD AIDS. 2013;24(9):703–11.
Article
PubMed
Google Scholar
Tong ML, Lin LR, Liu GL, Zhang HL, Zeng YL, Zheng WH, et al. Factors associated with serological cure and the serofast state of HIV-negative patients with primary, secondary, latent, and tertiary syphilis. PLoS One. 2013;8(7);e70102.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tsai JC, Lin YH, Lu PL, Shen NJ, Yang CJ, Lee NY, et al. Comparison of serological response to doxycycline versus benzathine penicillin G in the treatment of early syphilis in HIV-infected patients: a multi-center observational study. PLoS One. 2014;9(10);e109813.
Article
PubMed
PubMed Central
Google Scholar
Goeman J, Kivuvu M, Nzila N, Behets F, Edidi B, Gnaore E, et al. Similar serological response to conventional therapy for syphilis among HIV-positive and HIV-negative women. Genitourin Med. 1995;71(5):275–9.
CAS
PubMed
PubMed Central
Google Scholar
Long CM, Klausner JD, Leon S, Jones FR, Giron M, Cuadros J, et al. Syphilis treatment and HIV infection in a population-based study of persons at high risk for sexually transmitted disease/HIV infection in Lima. Peru Sex Transm Dis. 2006;33(3):151–5.
Article
CAS
PubMed
Google Scholar
Manavi K, McMillan A. The outcome of treatment of early latent syphilis and syphilis with undetermined duration in HIV-infected and HIV-uninfected patients. Int J STD AIDS. 2007;18(12):814–8.
Article
CAS
PubMed
Google Scholar
Riedner G, Rusizoka M, Todd J, Maboko L, Hoelscher M, Mmbando D, et al. Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N Engl J Med. 2005;353(12):1236–44.
Article
CAS
PubMed
Google Scholar
Rolfs RT, Joesoef MR, Hendershot EF, Rompalo AM, Augenbraun MH, Chiu M, et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Eng J Med. 1997;337(5):307–14.
Article
CAS
Google Scholar
Seña AC, Wolff M, Martin DH, Behets F, Van Damme K, Leone P, et al. Predictors of serological cure and serofast state after treatment in HIV-negative persons with early syphilis. Clin Infect Dis. 2011;53(11):1092–9.
Article
PubMed
PubMed Central
Google Scholar
Wu BR, Tsai MS, Yang CJ, Sun HY, Liu WC, Yang SP, et al. Spirochetemia due to Treponema pallidum using polymerase-chain-reaction assays in patients with early syphilis: prevalence, associated factors and treatment response. Clin Microbiol Infect. 2014;20(8):O524–7.
Article
CAS
PubMed
Google Scholar
Yang CJ, Lee NY, Chen TC, Lin YH, Liang SH, Lu PL, et al. One dose versus three weekly doses of benzathine penicillin G for patients co-infected with HIV and early syphilis: a multicenter, prospective observational study. PLoS One. 2014;9(10);e109667.
Article
PubMed
PubMed Central
Google Scholar
Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2010;64(3):34–48.
Google Scholar
Wassermann A, Neisser A, Bruck C. Eine serodiagnostische Reaktion bei Syphilis. Dtsch Med Wochenschr. 1906;32(19):745–6.
Article
Google Scholar
Pangborn MC. Isolation and purification of a serologically active phospholipid from beef heart. J Biol Chem. 1942;143:247–56.
CAS
Google Scholar
Matthews HM, Yang TK, Jenkin HM. Unique lipid composition of Treponema pallidum (Nichols virulent strain). Infect Immun. 1979;24(3):713–9.
CAS
PubMed
PubMed Central
Google Scholar
Fredriksson T, Hederstedt B, Rosengren S. A study on the Wassermann and TPI antibodies in relation to histopathological findings in T. pallidum infected animals and man. Acta Pathol Microbiol Scand. 1968;72(1):125–38.
Article
CAS
PubMed
Google Scholar
Lafond RE, Lukehart SA. Biological basis for syphilis. Clin Microbiol Rev. 2006;19(1):29–49.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hernández-Aguado I, Bolumar F, Moreno R, Pardo FJ, Torres N, Belda J, et al. False-positive tests for syphilis associated with human immunodeficiency virus and hepatitis B virus infection among intravenous drug abusers. Valencian Study Group on HIV Epidemiology. Eur J Clin Microbiol Infect Dis. 1998;17(11):784–7.
Article
PubMed
Google Scholar
Nandwani R, Evans DT. Are you sure it’s syphilis? A review of false positive serology. Int J STD AIDS. 1995;6(4):241–8.
CAS
PubMed
Google Scholar
Collart P, Borel LJ, Durel P. [Studies on late syphilis. Persistence of Treponema pallidum following penicillin therapy in experimental and human syphilis.][Article in French]. Clinique (Paris). 1964;59:653–7.
CAS
Google Scholar
Yobs AR, Clark Jr JW, Mothershed SE, Bullard JC, Artley CW. Further observations on the persistence of Treponema pallidum after treatment in rabbits and humans. Br J Vener Dis. 1968;44(2):116–30.
CAS
PubMed
PubMed Central
Google Scholar
Zhou P, Gu X, Lu H, Guan Z, Qian Y. Re-evaluation of serological criteria for early syphilis treatment efficacy: progression to neurosyphilis despite therapy. Sex Transm Infect. 2012;88(5):342–5.
Article
PubMed
Google Scholar
Gayet-Ageron A, Lautenschlager S, Ninet B, Perneger TV, Combescure C. Sensitivity, specificity and likelihood ratios of PCR in the diagnosis of syphilis: a systematic review and meta-analysis. Sex Transm Infect. 2013;89(3):251–6.
Article
PubMed
Google Scholar
Clement ME, Okeke NL, Hicks CB. Treatment of syphilis: a systematic review. JAMA. 2014;312(18):1905–17.
Article
PubMed
Google Scholar
Eagle H, Magnuson HJ, Fleischman R. Relation of the size of the inoculum and the age of the infection to the curative dose of penicillin in experimental syphilis, with particular reference to the feasibility of its prophylactic use. J Exp Med. 1947;85(4):423–40.
Article
CAS
PubMed
PubMed Central
Google Scholar
Eagle H, Magnuson HJ, Fleischman R. The effect of the method of administration on the therapeutic efficacy of sodium penicillin in experimental syphilis. Bull Johns Hopkins Hosp. 1946;79:168–89.
CAS
PubMed
Google Scholar
Sena AC, Wolff M, Behets F, Van Damme K, Martin DH, Leone P, et al. Response to therapy following retreatment of serofast early syphilis patients with benzathine penicillin. Clin Infect Diseases. 2013;56(3):420–2.
Article
CAS
Google Scholar
Baughn RE, Jorizzo JL, Adams CB, Musher DM. Ig class and IgG subclass responses to Treponema pallidum in patients with syphilis. J Clin Immunol. 1988;8(2):128–39.
Article
CAS
PubMed
Google Scholar
Baker-Zander SA, Roddy RE, Handsfield HH, Lukehart SA. IgG and IgM antibody reactivity to antigens of Treponema pallidum after treatment of syphilis. Sex Transm Dis. 1986;13(4):214–20.
Article
CAS
PubMed
Google Scholar
Tanaka S, Suzuki T. Anti-Treponema pallidum IgM, IgA, and IgG subclass antibody responses after treatment in patients with syphilis at various stages: 1. Assessments by enzyme-linked immunosorbent assay. Genitourin Med. 1990;66(3):171–7.
CAS
PubMed
PubMed Central
Google Scholar
Amanna IJ, Carlson NE, Slifka MK. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med. 2007;357(19):1903–15.
Article
CAS
PubMed
Google Scholar
Bonsignori M, Wiehe K, Grimm SK, Lynch R, Yang G, Kozink DM, et al. An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1. J Clin Invest. 2014;124(4):1835–43.
Article
CAS
PubMed
PubMed Central
Google Scholar
Haynes BF, Verkoczy L. AIDS/HIV. Host controls of HIV neutralizing antibodies. Science. 2014;344:588–9.
Article
PubMed
PubMed Central
Google Scholar
Verkoczy L, Chen Y, Zhang J, et al. Induction of HIV-1 broad neutralizing antibodies in 2F5 knock-in mice: selection against membrane proximal external region-associated autoreactivity limits T-dependent responses. J Immunol. 2013;191(5):2538–50.
Article
CAS
PubMed
Google Scholar
Verkoczy L, Chen Y, Bouton-Verville H, et al. Rescue of HIV-1 broad neutralizing antibody-expressing B cells in 2F5 VH x VL knockin mice reveals multiple tolerance controls. J Immunol. 2011;187(7):3785–97.
Article
CAS
PubMed
PubMed Central
Google Scholar
Verkoczy L, Kelsoe G, Moody MA, Haynes BF. Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies. Curr Opin Immun. 2011;23(3):383–90.
Article
CAS
Google Scholar
Verkoczy L, Diaz M, Holl TM, Ouyang YB, Bouton-Verville H, Alam SM, et al. Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic tolerance. Proc Natl Acad Sci U S A. 2010;107(1):181–6.
Article
CAS
PubMed
Google Scholar
Yang G, Holl TM, Liu Y, Li Y, Lu X, Nicely NI, et al. Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies. J Exp Med. 2013;210(2):241–56.
Article
CAS
PubMed
PubMed Central
Google Scholar
Moir S, Fauci AS. B cells in HIV infection and disease. Nat Rev Immunol. 2009;9(4):235–45.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lane HC, Masur H, Edgar LC, Whalen G, Rook AH, Fauci AS. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1983;309(8):453–8.
Article
CAS
PubMed
Google Scholar
Buchacz K, Patel P, Taylor M, Kerndt PR, Byers RH, Holmberg SD, et al. Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS. 2004;18(15):2075–9.
Article
PubMed
Google Scholar
Lynn WA, Lightman S. Syphilis and HIV: a dangerous combination. Lancet Infect Dis. 2004;4(7):456–66.
Article
CAS
PubMed
Google Scholar
French P, Gomberg M, Janier M, Schmidt B, van Voorst Vader P, Young H. IUSTI: 2008 European guidelines on the management of syphilis. Int J STD AIDS. 2009;20(5):300–9.
Article
CAS
PubMed
Google Scholar